Concord Biotech Ltd Stock Fundamentals

Concord Biotech Ltd Share Price
Detail Overview
Pharmaceuticals - Indian - Bulk Drugs & Formln M/SNSE
₹1,229.30
-41.40(-3.26%)
As on 23 Oct 2026 at 15:54
As of 23 Oct 2026 at 15:54, Concord Biotech Ltd is trading at ₹1,229.30. The 52-week range stands at ₹987.00–₹1,615.00, with a market cap of ₹12.86 thousand crore. At a P/E of 45.21 and a dividend yield of 0.61%, it is a mid-cap stock in the Pharmaceuticals sector.
Market Cap
₹12.86K Cr
PE Ratio
45.21
ROCE
17.41%

Concord Biotech Ltd Fundamentals

Market Cap₹12.86K Cr
ROE13.03%
P/E Ratio (TTM)45.21
EPS (TTM)₹27.18
P/B Ratio6.37
Dividend Yield0.61%
Industry P/E83.12
Book Value₹193.06
Debt to Equity0.00
Face Value₹1

Frequently asked questions

The Concord Biotech Ltd revenue for the latest reported period is ₹1,055 crore, compared with ₹1,200 crore in the corresponding previous period.

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now